The DOI matches its Crossref record; 39 of the 41 references it cites were found in a registry or an index.
The role of TNFα and TNF receptors in obesity and insulin resistance
Open accessAbstract
Abstract. Hotamisligil GS (Harvard University, Boston, Massachusetts, USA). The role of TNFα and TNF receptors in obesity and insulin resistance. (Minisymposium: Genes & Obesity). J Intern Med 1999; 245: 621–625. Insulin resistance, a smaller than expected response to a given dose of insulin, is associated with many common diseases including, ageing, polycystic ovarian disease, syndrome X, cancer, infections, trauma and, most significantly, obesity and type 2 diabetes mellitus. The biochemical basis of insulin resistance in type 2 diabetes has been the subject of many studies. Earlier studies have indicated that quantitative regulation of the insulin sensitive glucose transporters (Glut‐4) and insulin receptors themselves may contribute to this disorder, however, these two factors are probably inadequate to explain the extent of insulin resistance. This point also became apparent by the development of only mild hyperinsulinaemia in mice with a targeted mutation in the Glut‐4 gene. Studies on postreceptor defects in type 2 diabetes has recently focused on the intrinsic catalytic activity of the insulin receptor and downstream signalling events. A reduction in tyrosine phosphorylation of both the insulin receptor (IR) and the insulin receptor substrate‐1 (IRS‐1) has been noted in both animal and human type 2 diabetes. Importantly, this appears to occur in all of the major insulin‐sensitive tissues, namely the muscle, fat and liver. It is now clear that decreased signalling capacity of the insulin receptor is an important component of this disease. I will review some of the potential mechanisms underlying this deficiency.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TNF␣ is an important factor contributing to obesity-related insulin resistance (46).”
From Expression of Mfn2, the Charcot-Marie-Tooth Neuropathy Type 2A Gene, in Human Skeletal Muscle (2005) · cites this paper as [46]
In the citing paper
“Evidence indicates that inflammation causes insulin resistance”
From Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty (2018) · cites this paper as [283]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Self-citationRole of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Kern, P. A., Saghizadeh, M., Ong, J. M., Bosch, R. J., Deem, R., & Simsolo, R. B. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117899 · Cited by 1,305
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamışlıgil, G. S., Murray, D. L., Choy, L., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,220
Hotamışlıgil, G. S., Johnson, R. S., Distel, R. J., Ellis, R., Papaioannou, V. E., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.274.5291.1377 · Cited by 915
Hotamisligil, G. S., Budavari, A., Murray, D., & Spiegelman, B. M. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117495 · Cited by 819
The expression of TNF alpha by human muscle. Relationship to insulin resistance.
Saghizadeh, M., Ong, J. M., Garvey, W. T., Henry, R. R., & Kern, P. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118504 · Cited by 717
Cited by
Sorted by citations
Items 401–500 of 783
Mirhafez, S. R., Avan, A., Pasdar, A., Kazemi, E., Ghasemi, F., Tajbakhsh, A., Tabaee, S. S., Ferns, G. A., & Ghayour‐Mobarhan, M. (2015) · Gene · doi:10.1016/j.gene.2015.05.019 · Cited by 33
Gestational diabetes, inflammation, and late vascular disease
Volpe, L., Cianni, G. D., Lencioni, C., Cuccuru, I., Benzi, L., & Prato, S. D. (2007) · Journal of Endocrinological Investigation · doi:10.1007/bf03349231 · Cited by 32
Odamaki, M., Furuya, R., Kinumura, Y., Ikegaya, N., & Kumagai, H. (2005) · Nephron Clinical Practice · doi:10.1159/000088293 · Cited by 33
Xie, B., Jin, S. H., & Zhu, W.-J. (2013) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2013.1360 · Cited by 33
TNF-α and leptin activate the α-isoform of class II phosphoinositide 3-kinase
Ktori, C., Shepherd, P. R., & O’Rourke, L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00933-1 · Cited by 36
Adipocyte metabolism and the metabolic syndrome
Stears, A. J., & Byrne, C. D. (2001) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2001.00151.x · Cited by 33
Halimi, J.-M., Forhan, A., Balkau, B., Novak, M., Wilpart, E., Tichet, J., & Marre, M. (2001) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182670100800304 · Cited by 33
Inflammation in Heart Failure—Future Perspectives
Arvunescu, A. M., Ionescu, R. F., Creţoiu, S. M., Dumitrescu, S. I., Zaharia, O., & Nanea, I. T. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12247738 · Cited by 38
Zhou, L., Cheng, L., He, Y., Gu, Y., Wang, Y., & Wang, C. (2016) · Inflammation Research · doi:10.1007/s00011-016-0953-y · Cited by 32
An update on mode of action of metformin in modulation of meta-inflammation and inflammaging
Khodadadi, M., Jafari-Gharabaghlou, D., & Zarghami, N. (2022) · Pharmacological Reports · doi:10.1007/s43440-021-00334-z · Cited by 34
Rodríguez‐Rodríguez, E., Palmeros-Exsome, C., López-Sobaler, A. M., & Anta, R. M. O. (2010) · European Journal of Pediatrics · doi:10.1007/s00431-010-1260-1 · Cited by 32
Yang, Z., Miyahara, H., Takemura, S., & Hatanaka, A. (2011) · Lipids · doi:10.1007/s11745-011-3553-1 · Cited by 32
Adverse Effects of Reactive Oxygen Species on Vascular Reactivity in Insulin Resistance
Busija, D. W., Miller, A. W., Katakam, P. V. G., & Erdös, B. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1131 · Cited by 32
Rocha, P. M., Themudo-Barata, J. L., Teixeira, P. J., Ross, R., & Sardinha, L. B. (2008) · Metabolism · doi:10.1016/j.metabol.2008.01.003 · Cited by 32
Secretory products from human adipocytes impair endothelial function via nuclear factor κB
Kralisch, S., Sommer, G., Stangl, V., Köhler, U., Kratzsch, J., Stepan, H., Faber, R., Schubert, A., Lössner, U., Vietzke, A., et al. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.05.016 · Cited by 32
Lu, J., Chuang, L., Yang, W., Tai, T., Lai, M., Chen, P., Kao, J., Lee, C., & Lee, M. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.1007.x · Cited by 32
Immunomodulatory Effects of Aerobic Training in Obesity
Nickel, T., Hanssen, H., Emslander, I., Drexel, V., Hertel, G., Schmidt‐Trucksäss, A., Summo, C., Sisic, Z., Lambert, M., Hoster, E., et al. (2011) · Mediators of Inflammation · doi:10.1155/2011/308965 · Cited by 31
Panera, N., Corte, C. D., Crudele, A., Stronati, L., Nobili, V., & Alisi, A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2016.1110485 · Cited by 31
Kain, V., Kapadia, B. B., Viswakarma, N., Seshadri, S., Prajapati, B., Jena, P. K., Meda, C. L. T., Subramanian, M., Suraj, S. K., Kumar, S. T., et al. (2015) · Scientific Reports · doi:10.1038/srep15197 · Cited by 31
Jo, S. J., Kim, J. W., Choi, H. O., Kim, J. H., Kim, H. J., Woo, S., & Han, B. H. (2017) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.048 · Cited by 31
Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes
Chen, S., Sbuh, N., & Veedu, R. N. (2020) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0891 · Cited by 30
Reduced insulin receptor signaling in retinal Müller cells cultured in high glucose.
Jiang, Y., Pagadala, J., Miller, D. D., & Steinle, J. J. (2013) · Europe PMC (PubMed Central) · Cited by 31
Derosa, G., D’Angelo, A., Romano, D., & Maffioli, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020343 · Cited by 31
Witthuhn, B. A., & Bernlohr, D. (2001) · Cytokine · doi:10.1006/cyto.2001.0864 · Cited by 31
Fu, L., Isobe, K., Zeng, Q., Suzukawa, K., Takekoshi, K., & Kawakami, Y. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.01.028 · Cited by 30
Can brain dysfunction be a predisposing factor for metabolic syndrome?
Singh, R. B., Pella, D., Mechírová, V., & Otsuka, K. (2004) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(04)80011-8 · Cited by 30
Chen, C. (2010) · The Chinese Journal of Physiology · doi:10.4077/cjp.2010.amk078 · Cited by 35
Rapid Detection of Tumor Necrosis Factor-Alpha Using Quantum Dot-Based Optical Aptasensor
Ghosh, S., Datta, D., Chaudhry, S., Dutta, M. B., & Stroscio, M. A. (2018) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2018.2852261 · Cited by 30
The effect of leptin on Na+-H+ antiport (NHE 1) activity of obese and normal subjects erythrocytes
Konstantinou-Tegou, A., Kaloyianni, M. G., Bourikas, D., & Koliakos, G. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00639-6 · Cited by 30
Chang, Y., Lin, K., Wang, C.-L., Hsieh, M., Hsiao, P., & Shin, S. (2008) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.894 · Cited by 29
Soliman, M. M., NASSAN, M. A., & Ismail, T. A. (2016) · PubMed Central · Cited by 29
Progranulin promotes bone fracture healing via TNFR pathways in mice with type 2 diabetes mellitus
Ding, Y., Wei, J., Hettinghouse, A., Li, G., Li, X., Einhorn, T. A., & Liu, C.-J. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14568 · Cited by 29
Yuan, G., Shi, S., Jia, Q., Shi, J., Shi, S., Zhang, X., Shou, X., Zhu, X., & Hu, Y. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/6633402 · Cited by 30
Altered hepatic insulin signalling in male offspring of obese mice
Martin‐Gronert, M. S., Fernandez‐Twinn, D. S., Poston, L., & Ozanne, S. E. (2010) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174410000231 · Cited by 29
Participação do zinco na resistência à insulina
Marreiro, D. N., Geloneze, B., Tambascia, M. A., Lerário, A. C., Halpern, A., & Cozzolino, S. M. F. (2004) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302004000200005 · Cited by 29
Małyszko, J., Małyszko, J. S., Brzόsko, S., Wołczyński, S., & Myśliwiec, M. (2005) · American Journal of Nephrology · doi:10.1159/000085827 · Cited by 29
Chronic inflammation as predictor of 1‐year hospitalization and mortality in elderly population
de Gonzalo‐Calvo, D., de Luxán‐Delgado, B., Martínez‐Camblor, P., Rodríguez‐González, S., Macia, M. G., Suárez, F. M., Solano, J. J., Rodríguez‐Colunga, M. J., & Coto‐Montes, A. M. (2012) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2012.02689.x · Cited by 29
Colombo, M., Kruhøffer, M., Gregersen, S., Agger, A., Jeppesen, P., Orntoft, T. F., & Hermansen, K. (2005) · Metabolism · doi:10.1016/j.metabol.2005.07.005 · Cited by 29
Berberine Improves TNF-α-Induced Hepatic Insulin Resistance by Targeting MEKK1/MEK Pathway
Li, Y., Chen, X., Chen, Y., Yu, D., Jiang, R., Kou, X., Sheng, L., Liu, Y., & Song, Y. (2022) · Inflammation · doi:10.1007/s10753-022-01671-8 · Cited by 28
Slattery, M. L., Lundgreen, A., Torres-Mejı́a, G., Wolff, R. K., Hines, L. M., Baumgartner, K. B., & John, E. M. (2014) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.08.009 · Cited by 29
Abdelgadir, M., Karlsson, A. F., Berglund, L., & Berne, C. (2013) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-5-15 · Cited by 30
de Miguel‐Díez, J., García, T. G., & Puente‐Maestu, L. (2010) · Archivos de Bronconeumología · doi:10.1016/s0300-2896(10)70058-2 · Cited by 29
Kv1.3 potassium channel blockade as an approach to insulin resistance
Désir, G. V. (2005) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.9.3.571 · Cited by 28
Kv1.3: a potential pharmacological target for diabetes
Choi, B. H., & Hahn, S. J. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.133 · Cited by 28
Jiang, S., & Messina, J. L. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00148.2011 · Cited by 27
The impact of laparoscopy on bariatric surgery
Cottam, D. R., Nguyen, N. T., Eid, G. M., & Schauer, P. R. (2005) · Surgical Endoscopy · doi:10.1007/s00464-004-8164-y · Cited by 27
Faßhauer, M., Klein, J. C., Krahlisch, S., Lössner, U., Klier, M., Blüher, M., & Paschke, R. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780523 · Cited by 26
Promoter polymorphism in the macrophage migration inhibitory factor gene is associated with obesity
Sakaue, S., Ishimaru, S., Hizawa, N., Ohtsuka, Y., Tsujino, I., Honda, T., Suzuki, J., Kawakami, Y., Nishihira, J., & Nishimura, M. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803148 · Cited by 26
Franch, H. A., & Mitch, W. E. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141051 · Cited by 26
Tumor necrosis factor-related genes and colon and rectal cancer.
Slattery, M. L., Lundgreen, A., Bondurant, K. L., & Wolff, R. K. (2011) · PubMed Central · Cited by 26
Chen, X., Lei, T., Xia, T., Gan, L., & Yang, Z. (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1462-8902.2004.0346.x · Cited by 26
Peroxisome Proliferator Activator Receptors (PPAR), Insulin Resistance, and Cardiomyopathy
Nikolaidis, L. A., & Levine, T. B. (2004) · Cardiology in Review · doi:10.1097/01.crd.0000102419.52594.90 · Cited by 26
Derosa, G., Ragonesi, P. D., Carbone, A., Fogari, E., D’Angelo, A., Cicero, A. F. G., & Maffioli, P. (2012) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2012.734499 · Cited by 25
Pietraszek, A., Gregersen, S., & Hermansen, K. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.477 · Cited by 25
Santos, E. D., Pecquery, R., de Mazancourt, P., & Dieudonné, M. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-398313-8.00008-7 · Cited by 25
Shaaban, Z., Khoradmehr, A., Amiri‐Yekta, A., Shirazi, M. R. J., & Tamadon, A. (2019) · Europe PMC (PubMed Central) · doi:10.22038/ijbms.2019.14029 · Cited by 25
de Pablos-Velasco, P. L., Martínez-Martín, F., & Rodríguez-Pérez, F. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601401 · Cited by 25
Adipocytokine Changes Caused by Low-Carbohydrate Compared to Conventional Diets in Obesity
Seshadri, P., Samaha, F. F., Stern, L., Ahima, R. S., Daily, D. A., & Iqbal, N. (2005) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2005.3.66 · Cited by 25
Mondal, D., LaRussa, V. F., & Agrawal, K. C. (2001) · AIDS Research and Human Retroviruses · doi:10.1089/088922201753341988 · Cited by 24
Guo, D., Shi, Z., Luo, Y., Ding, R., & He, P. (2023) · BMC Oral Health · doi:10.1186/s12903-023-02764-y · Cited by 27
Role of PYK2 in the development of obesity and insulin resistance
Yu, Y., Ross, S. A., Halseth, A. E., Hollenbach, P. W., Hill, R. J., Gulve, E. A., & Bond, B. R. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.06.198 · Cited by 24
The brain–lipid–heart connection
Das, U. N. (2001) · Nutrition · doi:10.1016/s0899-9007(00)00578-5 · Cited by 24
Alkhatib, D. H., Jaleel, A., Tariq, M. N. M., Feehan, J., Apostolopoulos, V., Ismail, L. C., Stojanovska, L., & Dhaheri, A. S. A. (2021) · Nutrients · doi:10.3390/nu14010175 · Cited by 23
Visfatin and endothelial function in dialyzed patients
Małyszko, J., Małyszko, J. S., & Myśliwiec, M. (2009) · Nephrology · doi:10.1111/j.1440-1797.2009.01180.x · Cited by 23
Canto‐Cetina, T., Canizales‐Quinteros, S., de la Chesnaye, E., Coral‐Vázquez, R. M., Méndez, J. P., & Canto, P. (2007) · Hypertension in Pregnancy · doi:10.1080/10641950701372732 · Cited by 23
Höybye, C. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093229 · Cited by 22
Nisoli, E., Regianini, L., Bulbarelli, A., Briscini, L., Breacale, R., & Carruba, M. O. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801788 · Cited by 23
Manjari, V., Suresh, Y., Devi, M. M. S., & Das, U. N. (2001) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1054/plef.2000.0237 · Cited by 23
Peruzzi, F., Bergonzini, V., Aprea, S., Reiss, K., Sawaya, B. E., Rappaport, J., Amini, S., & Khalili, K. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.05.002 · Cited by 23
Insulin resistance and adipogenesis: Role of transcription and secreted factors
Penkov, D., Egorov, A. D., Мозговая, М. Н., & Va, T. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913010021 · Cited by 24
Ghani, R. A., Yaakob, I. B., Wahab, N. A., Zainudin, S., Mustafa, N., Sukor, N., Mohamud, W. N. W., Kadir, K. A., & Kamaruddin, N. A. (2013) · Journal of clinical lipidology · doi:10.1016/j.jacl.2013.04.004 · Cited by 22
Derosa, G., Maffioli, P., D’Angelo, A., Fogari, E., Bianchi, L., & Cicero, A. F. G. (2011) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2011.01.003 · Cited by 22
RetractedThe complex liaison between cachexia and tumor burden (Review)
Barbaro, A. D. L. (2015) · Oncology Reports · doi:10.3892/or.2015.4164 · Cited by 22
Derosa, G., Cicero, A. F. G., D’Angelo, A., & Maffioli, P. (2019) · Phytotherapy Research · doi:10.1002/ptr.6272 · Cited by 22
Moraes, J. C., do Amaral, M. E. C., Picardi, P. K., Calegari, V. C., Romanatto, T., Echeverry, M. B., Chiavegatto, S., Saad, M. J. A., & Velloso, L. A. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.07.042 · Cited by 22
Faßhauer, M., Klein, J. C., Lössner, U., & Paschke, R. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750727 · Cited by 23
At the interface of environment-immune interactions: Cytokine and growth-factor receptors
Broussard, S. R., Zhou, J. H., Venters, H., Bluthé, R.-M., Freund, G. G., Johnson, R. W., Dantzer, R., & Kelley, K. W. (2001) · Journal of Animal Science · doi:10.2527/jas2001.79e-supple268x · Cited by 22
Proinflammatory Cytokines Mediate GPCR Dysfunction
Mohan, M. L., Vasudevan, N. T., & Prasad, S. V. N. (2017) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000456 · Cited by 22
The Role of Obesity in the Immunopathogenesis of COVID-19 Respiratory Disease and Critical Illness
Kuperberg, S. J., & Navetta‐Modrov, B. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0236tr · Cited by 22
Proinsulin C-peptide: Friend or foe in the development of diabetes-associated complications?
Nordquist, L. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s3955 · Cited by 21
Metabolic effects of dietary conjugated linoleic acid (CLA) isomers in rats
Akahoshi, A., Koba, K., KAKU-OHKURA, S., Kaneda, N., Goto, C., Sano, H., Iwata, T., Yamauchi, Y., Tsutsumi, K., & Sugano, M. (2003) · Nutrition Research · doi:10.1016/j.nutres.2003.08.004 · Cited by 21
Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview
Ross, J. S., Russo, S. B., Chavis, G. C., & Cowart, L. A. (2014) · Clinical Lipidology · doi:10.2217/clp.14.37 · Cited by 20
IGF-IR in neuroprotection and brain tumors
Gualco, E. (2009) · Frontiers in bioscience · doi:10.2741/3249 · Cited by 21
Reduced Histone H3K9 Acetylation of Clock Genes and Abnormal Glucose Metabolism in ob/ob Mice
Ishikawa-Kobayashi, E., Ushijima, K., Ando, H., Maekawa, T., Takuma, M., Furukawa, Y., & Fujimura, A. (2012) · Chronobiology International · doi:10.3109/07420528.2012.706765 · Cited by 20
Méndez-García, L. A., Trejo‐Millán, F., Martínez‐Reyes, C. P., Manjarrez‐Reyna, A. N., Esquivel‐Velázquez, M., Meléndez, G., Islas‐Andrade, S., Rojas‐Bernabé, A., Kzhyshkowska, J. G., & Escobedo, G. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12716 · Cited by 20
Figueiredo, M. S., de Moura, E. G., Lisboa, P. C., Troina, A. A., Trevenzoli, I. H., OLIVEIRA, E. B. D., Boaventura, G. T., & Passos, M. C. D. F. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.06.018 · Cited by 20
Lionetti, L., Sica, R., Mollica, M. P., & Putti, R. (2013) · Food and Nutrition Sciences · doi:10.4236/fns.2013.49a1017 · Cited by 19
Interactions of Glucose Metabolism and Chronic Heart Failure
Clodi, M., Resl, M., Stelzeneder, D., Pacini, G., Tura, A., Mörtl, D., Struck, J., Morgenthaler, N. G., Bergmann, A., Riedl, M., et al. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1081211 · Cited by 19
Zubiría, M. G., Vidal‐Bravo, J., Spinedi, E., & Giovambattista, A. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12308 · Cited by 18
Effects of canrenone in patients with metabolic syndrome
Derosa, G., Bonaventura, A., Bianchi, L., Romano, D., D’Angelo, A., Fogari, E., & Maffioli, P. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.832756 · Cited by 18
Straub, S. V., Perez, S. M., Tan, B., Coughlan, K. A., Trebino, C. E., Cosgrove, P. G., Buxton, J. M., Kreeger, J. M., & Jackson, V. M. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00076.2011 · Cited by 18
Gálvez, I., Navarro, M. D. C., Martín-Cordero, L., Otero, E., Hinchado, M. D., & Ortega, E. (2022) · Nutrients · doi:10.3390/nu14030612 · Cited by 21
Johnson, D. R., O’Connor, J. C., Satpathy, A. T., & Freund, G. G. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74017-1 · Cited by 19
Joffe, Y. T., van der Merwe, L., Collins, M., Carstens, M., Evans, J., Lambert, E. V., & Goedecke, J. H. (2011) · Genes & Nutrition · doi:10.1007/s12263-011-0213-2 · Cited by 18
Bhatnager, R., Jalthuria, J., Sehrawat, R., Nanda, S., & Dang, A. S. (2018) · Cytokine · doi:10.1016/j.cyto.2018.11.004 · Cited by 19
Dong, T. S., Aby, E. S., Benhammou, J. N., Kawamoto, J. K., Han, S.-H., May, F. P., & Pisegna, J. R. (2018) · World Journal of Hepatology · doi:10.4254/wjh.v10.i9.612 · Cited by 17
Koufakis, T., Dimitriadis, G., Metallidis, S., Zebekakis, P. E., & Kotsa, K. (2021) · Obesity Reviews · doi:10.1111/obr.13231 · Cited by 19
KAHL, S., Nowotny, B., Piepel, S., Nowotny, P., Straßburger, K., Herder, C., Pacini, G., & Roden, M. (2014) · Diabetologia · doi:10.1007/s00125-014-3328-3 · Cited by 18
Schwartze, J. T., Landgraf, K., Spielau, U., Rockstroh, D., Löffler, D., Kratzsch, J., Kiess, W., & Körner, A. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.54 · Cited by 16
Pathak, A., Smih, F., Galinier, M., Verwaerde, P., Rouet, P., Philip‐Couderc, P., Montastruc, J., & Sénard, J. (2004) · International Journal of Obesity · doi:10.1038/sj.ijo.0802751 · Cited by 17
Metadata
- Authors
- Hotamisligil, G. S.
- Venue
- Journal of Internal Medicine
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 245
- Issue
- 6
- Pages
- 621-625
- ISSN
- 0954-6820 (ISSN-L)
- 1365-2796
- OpenAlex
- W2009818179
- Cited by
- 780
- References
- 41
- Citations by year
- 2026: 5 · 2025: 14 · 2024: 13 · 2023: 9 · 2022: 15 · 2021: 24 · 2020: 7 · 2019: 16 · 2018: 23 · 2017: 25 · 2016: 24 · 2015: 19 · 2014: 25 · 2013: 34 · 2012: 31
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- TNF-α, TNF receptor, obesity, insulin resistance, type 2 diabetes, insulin receptor signaling, tyrosine phosphorylation, IRS-1, GLUT4, postreceptor defect
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Mice, Transgenic, Obesity, Tumor Necrosis Factor-alpha, Receptors, Tumor Necrosis Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review